Eight of the patients had both a KIT mutation and RUNX1-RUNX1T1; these individuals represented 53% of AML with KIT mutation cases and 67% of AML with RUNX1-RUNX1T1 cases. The gene discussed is RUNX1; the disease is acute myeloid leukemia.